Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Machine learning approaches to predict lupus disease activity from gene expression data.

Kegerreis B, Catalina MD, Bachali P, Geraci NS, Labonte AC, Zeng C, Stearrett N, Crandall KA, Lipsky PE, Grammer AC.

Sci Rep. 2019 Jul 3;9(1):9617. doi: 10.1038/s41598-019-45989-0.

2.

Gene expression analysis delineates the potential roles of multiple interferons in systemic lupus erythematosus.

Catalina MD, Bachali P, Geraci NS, Grammer AC, Lipsky PE.

Commun Biol. 2019 Apr 23;2:140. doi: 10.1038/s42003-019-0382-x. eCollection 2019.

3.

Genomic Identification of Low-Density Granulocytes and Analysis of Their Role in the Pathogenesis of Systemic Lupus Erythematosus.

Kegerreis BJ, Catalina MD, Geraci NS, Bachali P, Lipsky PE, Grammer AC.

J Immunol. 2019 Jun 1;202(11):3309-3317. doi: 10.4049/jimmunol.1801512. Epub 2019 Apr 24.

PMID:
31019061
4.

Identification of alterations in macrophage activation associated with disease activity in systemic lupus erythematosus.

Labonte AC, Kegerreis B, Geraci NS, Bachali P, Madamanchi S, Robl R, Catalina MD, Lipsky PE, Grammer AC.

PLoS One. 2018 Dec 18;13(12):e0208132. doi: 10.1371/journal.pone.0208132. eCollection 2018.

5.

A highly purified form of staphylococcal protein A alleviates murine immune thrombocytopenia (ITP).

Kapur R, Catalina MD, Aslam R, Speck ER, Francovitch RF, Semple JW.

Br J Haematol. 2018 Nov;183(3):501-503. doi: 10.1111/bjh.14985. Epub 2017 Oct 19. No abstract available.

PMID:
29048127
6.

Drug repositioning in SLE: crowd-sourcing, literature-mining and Big Data analysis.

Grammer AC, Ryals MM, Heuer SE, Robl RD, Madamanchi S, Davis LS, Lauwerys B, Catalina MD, Lipsky PE.

Lupus. 2016 Sep;25(10):1150-70. doi: 10.1177/0961203316657437. Review.

PMID:
27497259
7.

Role of specific CD8+ T cells in the severity of a fulminant zoonotic viral hemorrhagic fever, hantavirus pulmonary syndrome.

Kilpatrick ED, Terajima M, Koster FT, Catalina MD, Cruz J, Ennis FA.

J Immunol. 2004 Mar 1;172(5):3297-304.

8.

Phenotypic and functional heterogeneity of EBV epitope-specific CD8+ T cells.

Catalina MD, Sullivan JL, Brody RM, Luzuriaga K.

J Immunol. 2002 Apr 15;168(8):4184-91.

9.

Infrequent detection of HIV-1-specific, but not cytomegalovirus-specific, CD8(+) T cell responses in young HIV-1-infected infants.

Scott ZA, Chadwick EG, Gibson LL, Catalina MD, McManus MM, Yogev R, Palumbo P, Sullivan JL, Britto P, Gay H, Luzuriaga K; PACTG(Pediatric AIDS Clinical Trial Group) 345 Investigators.

J Immunol. 2001 Dec 15;167(12):7134-40.

10.

Differential evolution and stability of epitope-specific CD8(+) T cell responses in EBV infection.

Catalina MD, Sullivan JL, Bak KR, Luzuriaga K.

J Immunol. 2001 Oct 15;167(8):4450-7. Erratum in: J Immunol 2001 Nov 15;167(10):6045.

11.

Normal hematopoiesis and inflammatory responses despite discrete signaling defects in Galpha15 knockout mice.

Davignon I, Catalina MD, Smith D, Montgomery J, Swantek J, Croy J, Siegelman M, Wilkie TM.

Mol Cell Biol. 2000 Feb;20(3):797-804.

13.

Circulating activated platelets reconstitute lymphocyte homing and immunity in L-selectin-deficient mice.

Diacovo TG, Catalina MD, Siegelman MH, von Andrian UH.

J Exp Med. 1998 Jan 19;187(2):197-204.

14.

The route of antigen entry determines the requirement for L-selectin during immune responses.

Catalina MD, Carroll MC, Arizpe H, Takashima A, Estess P, Siegelman MH.

J Exp Med. 1996 Dec 1;184(6):2341-51.

Supplemental Content

Loading ...
Support Center